Diagnostic News and Research

RSS

FNAC plays an increased role in the diagnosis of bone lesions

In recent years, fine-needle aspiration cytology (FNAC) has become a widely accepted procedure in the diagnosis of bone lesions. Rapid progress in immunocytochemistry and molecular genetics has increased the role of FNAC in the investigation of primary bone lesions.

4 Dec 2009

New discoveries to treat life-threatening blood disorder presented at ASH annual meeting

A genetic variation that may indicate a patient's risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is one of several medical discoveries scientists at cancer diagnostics leader Quest Diagnostics will present during the 51st American Society of Hematology (ASH) Annual Meeting and Exposition, December 5-8, 2009, in New Orleans, LA.

4 Dec 2009

New Center for Digestive Care to care for all aspects of digestive disease

The Center for Digestive Care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has been established with a mission to provide high-quality patient care, research and education for all aspects of digestive disease.

4 Dec 2009

RevMed introduces its proprietary suite of MRI software products at RSNA 2009

Revolutions Medical Corporation ("RevMed" or the "Company"), producers of the RevVac safety syringe, RevColor, RevDisplay and Rev3D MRI Technology, today announced that it introduced its proprietary suite of MRI software products at this week's Radiology Society of North America (RSNA) annual meeting with great success.

4 Dec 2009

KFDA approves RPC's Onko-Sure in Vitro Diagnostic cancer test

US-based pharmaceutical company Radient Pharmaceuticals Corporation (RPC) announced today the Korean Food & Drug Administration (KFDA) has approved RPC's Onko-Sure™ in Vitro Diagnostic cancer test for routine clinical testing and government reimbursement throughout Korea.

4 Dec 2009

Duke Medicine creates DCHI to provide campus focus for health informatics

In response to the increasingly critical role of healthcare information technologies in the evolving healthcare delivery system, Duke Medicine has created the Duke Center for Health Informatics (DCHI) to provide a campus focus for health informatics.

4 Dec 2009

Usefulness of heart rate variability as a diagnostic for identifying dysfunction established

According to Dr. Daniel Weiss, a recent study of heart rate autonomic markers, and cardiac mortality published in the November issue of Heart Rhythm provides additional support for the usefulness of heart rate variability as a diagnostic for identifying dysfunction (neuropathy in diabetics and others) and cardiovascular mortality, including fatal arrhythmia or sudden cardiac death.

4 Dec 2009

Geisinger Medical Center opens new ‘Vestibular and Balance Center’

Geisinger Medical Center recently opened a new Otolaryngology Head and Neck Surgery - Vestibular and Balance Center to help patients who are affected by vertigo, dizziness or balance problems.

4 Dec 2009

New biochemical probe may help in identifying toxic proteins associated with Alzheimer's disease

Alzheimer's disease (AD) is one of the most heartbreaking diagnoses a person can receive. This irreversible, progressive brain disease slowly destroys memory and thinking skills and eventually even the ability to carry out the simplest tasks

4 Dec 2009

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

3 Dec 2009

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

3 Dec 2009

Sodexo launches 'Better Tomorrow Plan' to meet the challenges of community and environmental practices

Sodexo (PARIS:SW) (OTCBB:SDXAY), world leader in Quality of Life solutions, announced today the creation of the "Better Tomorrow Plan," designed to better respond to the challenges of proper Nutrition, Health and Wellness, Local communities and Environment.

3 Dec 2009

Biomoda appeals N.M. congressional delegation to support Lung Cancer Mortality legislation

Cancer diagnostics company Biomoda, Inc. (OTCBB: BMOD) today urged the New Mexico congressional delegation to support the Lung Cancer Mortality Reduction Act of 2009, which calls for a comprehensive federal program to achieve a 50% reduction in the mortality rate of lung cancer by 2016.

3 Dec 2009

Novel multi-analyte approach to develop urine-biomarker based diagnostic assay to be presented

Predictive Biosciences today announced that Company scientists will be presenting a novel multi-analyte approach to the development of a non-invasive, urine-biomarker based diagnostic assay during the 10th Annual Meeting of the Society of Urologic Oncology (SUO).

3 Dec 2009

AclarusDx Alzheimer’s test now available as RUO product

ExonHit Therapeutics is pleased to announce that AclarusDx™ Alzheimer’s test (formerly known as EHT Dx21), its blood-based test for the detection of Alzheimer’s disease (AD), is now available as a Research Use Only (RUO) product for pharmaceutical companies and leading academic centers conducting clinical trials in Alzheimer’s disease.

3 Dec 2009

LSI collaborates with United Healthcare to meet the growing demand for spinal procedures

Laser Spine Institute (LSI), the leader in minimally invasive spinal surgery, is pleased to announce a partnership with United Healthcare and affiliates after an extensive six-month negotiation and clinical review process.

3 Dec 2009

Jupiter Medical Center deploys GE Healthcare's Signa HDx 1.5T MRI system

Jupiter Medical Center has incorporated one of the most advanced diagnostic tools available into its imaging program, the new Signa HDx 1.5T MRI system from GE Healthcare. The system delivers highly detailed images of the human body with increased speed, better resolution and unique applications, including dual breast scanning and non-contrast vascular imaging for patients with renal dysfunction.

3 Dec 2009

Earlier diagnosis of cancer saves 5,000 to 10,000 lives each year, says Professor Mike Richards

Earlier diagnosis of people with cancer could save between 5,000 and 10,000 lives each year, Professor Mike Richards, the National Cancer Director for England, has claimed.

3 Dec 2009

GammaL c device provides accurate lesion localization and facilitates needle-guided biopsy

Breast-Specific Gamma Imaging (BSGI) is a molecular breast imaging technique increasingly being used in the diagnostic workup of patients with indeterminate mammograms and has demonstrated the ability to detect cancers missed by mammography and ultrasound.

2 Dec 2009

Novel approach to detect flaws in defense against breast cancer earns Era of Hope Scholar Award

A novel approach to detecting and targeting flaws in first line of defense against cancer has earned an Era of Hope Scholar Award from the U.S. Department of Defense for a scientist at The University of Texas M. D. Anderson Cancer Center.

2 Dec 2009

Diagnostic News and Research

FNAC plays an increased role in the diagnosis of bone lesions

New discoveries to treat life-threatening blood disorder presented at ASH annual meeting

New Center for Digestive Care to care for all aspects of digestive disease

RevMed introduces its proprietary suite of MRI software products at RSNA 2009

KFDA approves RPC's Onko-Sure in Vitro Diagnostic cancer test

Duke Medicine creates DCHI to provide campus focus for health informatics

Usefulness of heart rate variability as a diagnostic for identifying dysfunction established

Geisinger Medical Center opens new ‘Vestibular and Balance Center’

New biochemical probe may help in identifying toxic proteins associated with Alzheimer's disease

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Sodexo launches 'Better Tomorrow Plan' to meet the challenges of community and environmental practices

Biomoda appeals N.M. congressional delegation to support Lung Cancer Mortality legislation

Novel multi-analyte approach to develop urine-biomarker based diagnostic assay to be presented

AclarusDx Alzheimer’s test now available as RUO product

LSI collaborates with United Healthcare to meet the growing demand for spinal procedures

Jupiter Medical Center deploys GE Healthcare's Signa HDx 1.5T MRI system

Earlier diagnosis of cancer saves 5,000 to 10,000 lives each year, says Professor Mike Richards

GammaL c device provides accurate lesion localization and facilitates needle-guided biopsy

Novel approach to detect flaws in defense against breast cancer earns Era of Hope Scholar Award

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News